• Erastin as a Ferroptosis Inducer: Workflows & Advanced Uses

  2026-06-18

  Erastin is a precision ferroptosis inducer empowering cancer biology and developmental research with selective, iron-dependent cell death. This article details optimized experimental workflows, troubleshooting strategies, and highlights the latest insights from spatial transcriptomics in developmental disease modeling.

• Partial BACE Inhibition Lowers Amyloid Beta Without Synaptic

  2026-06-17

  Satir et al. (2020) reveal that reducing amyloid beta (Aβ) production by up to 50% via partial β-secretase (BACE) inhibition does not impair synaptic transmission in cultured neurons. These findings refine therapeutic strategies for Alzheimer's disease by supporting moderate BACE inhibition as a safer approach, potentially mitigating adverse cognitive effects observed in prior clinical trials.

• Microglial BDNF Drives Arketamine’s Antidepressant Effects v

  2026-06-17

  This study uncovers a microglial BDNF-dependent mechanism underlying arketamine’s rapid and sustained antidepressant-like effects in mice. By elucidating how microglial BDNF activates specific cortico-accumbal circuits, it advances our understanding of novel neurobiological pathways for depression treatment.

• Pharmacological SMYD2 Inhibition Reduces Renal Fibrosis and

  2026-06-16

  This study demonstrates that pharmacological inhibition of SMYD2 using AZ505 protects against cisplatin-induced renal fibrosis and inflammation in a chronic kidney disease (CKD) model. The findings provide mechanistic insight into the role of SMYD2 in renal pathology and highlight its value as a therapeutic target in fibrotic disease.

• Calcitriol in Reproductive Biology: Unraveling VDR-Driven De

  2026-06-16

  Explore how Calcitriol, the active metabolite of vitamin D3, orchestrates endometrial decidualization through vitamin D receptor signaling. This article uniquely bridges advanced molecular insights with protocol optimization, offering practical guidance for immune modulation and reproductive research.

• Cholesterol as the Principal Sterol in Lipid Nanoparticle Re

  2026-06-15

  Cholesterol’s biophysical role is pivotal in engineering lipid nanoparticles for mRNA delivery, particularly in localized therapies like intravesical p21 mRNA–LNP for bladder cancer. This article details applied workflows, protocol critical points, and troubleshooting steps leveraging APExBIO’s high-purity cholesterol, connecting recent advances to practical outcomes for membrane fluidity and lipid metabolism research.

• Crystal Violet Staining: Precision Tools for Translational I

  2026-06-15

  Explore how advanced nuclear staining dyes like Crystal Violet Staining Solution are powering translational research. This article integrates mechanistic insight, rigorous protocol guidance, and strategic context—bridging cutting-edge findings in molecular epidemiology with proven methods for cell-based assay quantification. Learn how to optimize experimental workflows, interpret biofilm and proliferation data, and stay ahead in the evolving landscape of antifungal resistance and virulence surveillance.

• A Genetically Encoded Biosensor for Bacterial NADH/NAD+ Redo

  2026-06-14

  The referenced study introduces a genetically encoded, ratiometric biosensor for monitoring the NADH/NAD+ redox ratio in bacteria, leveraging the redox-responsive transcription factor Rex. This innovation enables high-throughput, noninvasive analysis of redox metabolism, supporting both fundamental bacterial physiology research and metabolic engineering.

• Mitigating Pollen Interference in Fluorescence-Based Hazard

  2026-06-13

  The reference study introduces a robust data-processing workflow to eliminate pollen-derived spectral interference in excitation–emission matrix fluorescence spectroscopy (EEM) for the classification of hazardous bioaerosols. By integrating signal transformation and machine learning, the method notably enhances accuracy and reliability in detecting toxins and pathogens, offering practical advances for real-time bioaerosol monitoring.

• JAK Inhibitors and Endothelial Dysfunction in Inflammatory S

  2026-06-12

  This article analyzes Zavoriti and Miossec's comparative study on the vascular effects of different JAK inhibitors—including tofacitinib citrate—on human endothelial cells exposed to inflammatory cytokines. The research reveals nuanced anti-inflammatory actions and unexpected procoagulant responses, providing important context for cardiovascular safety and immune regulation research.

• Streptavidin-FITC: Precision Fluorescent Detection in Biotin

  2026-06-12

  Streptavidin-FITC empowers ultra-sensitive, quantitative detection of biotinylated molecules in immunohistochemistry, flow cytometry, and advanced nanoparticle tracking. Leveraging high-affinity binding and robust fluorescence, this conjugate streamlines workflows and drives data reliability—especially when decoding complex intracellular trafficking dynamics.

• CUDC-907: Practical Guide for Dual PI3K and HDAC Inhibition

  2026-06-11

  CUDC-907 addresses the need for simultaneous PI3K/AKT and histone deacetylase inhibition in cancer cell research models, offering a defined approach to studying cell signaling, apoptosis, and cell cycle arrest. This compound is strictly for controlled laboratory use and should not be applied in diagnostic or therapeutic workflows.

• Z-Ligustilide and Cisplatin Target PLPP1 to Reverse Resistan

  2026-06-11

  This study demonstrates that combining Z-ligustilide with cisplatin sensitizes cisplatin-resistant lung cancer cells by modulating PLPP1-mediated phospholipid synthesis. The integration of metabolomic and transcriptomic analyses reveals mechanistic details, suggesting new avenues for overcoming chemotherapy resistance.

• Dual Luciferase Reporter Gene System: Precision in Dynamic G

  2026-06-10

  Explore how the Dual Luciferase Reporter Gene System advances gene expression regulation research with high-throughput, precise bioluminescence assays. This article provides a deep dive into the unique scientific strengths, technical innovations, and practical assay considerations for researchers seeking robust transcriptional insights.

• STING and CD40 Competition Regulates IRF4 B Cell Activation

  2026-06-10

  A recent study uncovers how competitive binding between CD40 and STING with TRAF2 drives IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). These findings clarify mechanisms of antitumor immunity and highlight new biomarker and therapeutic opportunities in ESCC immunology.

531 records 13/36 page Previous Next First page 上5页 1112131415 下5页 Last page